meglumine has been researched along with Coronary Occlusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beek, AM; Eerenberg, ES; Heymans, MW; Hollander, MR; Horrevoets, AJ; Jansen, MF; Knaapen, P; Levi, MM; Marcu, CB; Niessen, HW; Nijveldt, R; Robbers, LF; Teunissen, PF; van Rossum, AC; van Royen, N | 1 |
| Bucknor, M; Do, L; Higgins, CB; Jacquier, A; Kan, YW; Martin, A; Saeed, M; Saloner, D; Su, H; Ursell, P | 1 |
2 other study(ies) available for meglumine and Coronary Occlusion
| Article | Year |
|---|---|
Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage.
Topics: Adult; Aged; Animals; Balloon Occlusion; Cardiomyopathies; Contrast Media; Coronary Occlusion; Coronary Thrombosis; Disease Models, Animal; Female; Hemorrhage; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging, Cine; Male; Meglumine; Microvessels; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Necrosis; Organometallic Compounds; Percutaneous Coronary Intervention; Sus scrofa | 2013 |
Permanent coronary artery occlusion: cardiovascular MR imaging is platform for percutaneous transendocardial delivery and assessment of gene therapy in canine model.
Topics: Analysis of Variance; Animals; Contrast Media; Coronary Occlusion; Dogs; Genetic Therapy; Magnetic Resonance Imaging, Interventional; Meglumine; Organometallic Compounds; Vascular Endothelial Growth Factor A | 2008 |